No evidence for PERV release by islet cells from german landrace pigs

Annals of Transplantation

Volumn 13, Issue 4, 2008, Pages 59-66

  Irgang, Markus ^a   Laue, Christine ^b   Velten, Florian ^b   Kurth, Reinhard ^a   Schrezenmeir, Jürgen ^b   Denner, Joachim ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b Kiel and Lungen Clinic Grosshansdorf   (Germany)

Author keywords

Diabetes; Islet cells; Porcine endogenous retroviruses (pervs); Xenotransplantation

Indexed keywords

MESSENGER RNA; NEOMYCIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL STRAIN HEK293; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO; FLUORESCENCE ACTIVATED CELL SORTING; GENOME; HUMAN; HUMAN CELL; INCUBATION TIME; MICROCHIMERISM; NONHUMAN; PANCREAS ISLET CELL; PORCINE ENDOGENOUS RETROVIRUS; PROTEIN EXPRESSION; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; TARGET CELL; VIRUS PARTICLE; ANIMAL; DIABETES MELLITUS; DISEASE TRANSMISSION; ENDOGENOUS RETROVIRUS; GENETICS; GERMANY; ISOLATION AND PURIFICATION; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; RETROVIRUS INFECTION; SAFETY; STANDARD; VIROLOGY; VIRUS GENOME; XENOGRAFT;

ANIMALS; DIABETES MELLITUS; ENDOGENOUS RETROVIRUSES; GENOME; GENOME, VIRAL; GERMANY; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; RETROVIRIDAE INFECTIONS; SAFETY; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 65349195813     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. http://www.library.nhs.uk/diabetes/ViewResource.aspx?resID=261624
2. Bolli GB, Di Marchi RD, Park GD et al: Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia, 1999; 42: 1151-67
3. Berney T, Buhler L, Caulfield A et al: Transplantation of islets of Langerhans: new developments. Swiss Med Wkly, 2001; 131: 671-80
4. Alejandro R, Lehmann R, Ricordi C et al: Longterm function (6 years) of islet allografts in type 1 diabetes. Diabetes, 1997; 46: 1983-89
5. Meyer C, Hering BJ, Grossmann R et al: Improved glucose counterregulation and autonomic symptoms after intraportal islet transplants alone in patients with long-standing type I diabetes mellitus. Transplantation, 1998; 66: 233-40
6. Oberholzer J, Triponez F, Mage R et al: Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations. Transplantation, 2000; 69: 1115-23
7. Shapiro AM, Lakey JR, Ryan EA et al: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med, 2000; 343: 230-38
8. Groth CG, Korsgren O, Tibell A et al: Transplantation of porcine fetal pancreas to diabetic patients. Lancet, 1994; 344: 1402-4
9. Heneine W, Tibell A, Switzer WM et al: No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet, 1998; 352: 695-99
10. Groth CG, Korsgren O, Wennberg L et al: Pig-to-human islet transplantation. Transplant Proc, 1998; 30: 3809-10
11. Newgard CB, Clark S, BeltrandelRio H et al: Engineered cell lines for insulin replacement in diabetes: current status and future prospects. Diabetologia, 1997; 40(2): S42-47
12. Ramiya VK, Maraist M, Arfors KE et al: Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med, 2000; 6: 278-82
13. Sachs DH: The pig as a potential xenograft donor. Vet Immunol Immunopathol, 1994; 43: 185-91.
14. Costa C, Zhao L, Burton WV et al: Transgenic pigs designed to express human CD59 and H-transferase to avoid humoral xenograft rejection. Xenotransplantation, 2002; 9: 45-57
15. Ramsoondar JJ, Machaty Z, Costa C et al: Production of {alpha}1,3-galactosyltransferase-knockout cloned pigs expressing human {alpha}1,2-fucosylosyltransferase. Biol Reprod, 2003; 69(2): 437-45
16. Buhler L, Friedman T, Iacomini J, Cooper DK: Xenotransplantation - state of the art -update 1999. Front Biosci, 1999; 4: D416-32
17. Patience C, Switzer WM, Takeuchi Y et al: Multiple groups of novel retroviral genomes in pigs and related species. J Virol; 2001; 75: 2771-75
18. Patience C, Takeuchi Y, Weiss RA: Infection of human cells by an endogenous retrovirus of pigs. Nat Med, 1997; 3: 282-86
19. Wilson CA, Wong S, Muller J et al: Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol, 1998; 72: 3082-87
20. Specke V, Tacke SJ, Boller K et al: Porcine endogenous retroviruses: in vitro host range and attempts to establish small animal models. J Gen Virol, 2001; 82: 837-44
21. Blusch JH, Patience C, Martin U: Pig endogenous retroviruses and xenotransplantation. Xenotransplantation, 2002; 9: 242-51
22. Martin U, Winkler ME, Id M et al: Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation, 2000; 7: 138-42
23. Denner J: Immunosuppression by retroviruses: implications for xenotransplantation. Ann N Y Acad Sci, 1998; 862: 75-86
24. Jin H, Inoshima Y, Wu D et al: Expression of porcine endogenous retrovirus in peripheral blood leukocytes from ten different breeds. Transpl Infect Dis, 2000; 2: 11-14
25. Mang R, Maas J, Chen X et al: Identification of a novel type C porcine endogenous retrovirus: evidence that copy number of endogenous retroviruses increases during host inbreeding. J Gen Virol, 2001; 82: 1829-34
26. Tacke SJ, Specke V, Denner J: Differences in release and determination of subtype of porcine endogenous retroviruses produced by stimulated normal pig blood cells. Intervirology, 2003; 46: 17-24
27. Oldmixon BA, Wood JC, Ericsson TA et al: Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J Virol, 2002; 76: 3045-48
28. Langford GA, Galbraith D, Whittam AJ et al: In vivo analysis of porcine endogenous retrovirus expression in transgenic pigs. Transplantation, 2001; 72: 1996-2000
29. Tacke SJ, Kurth R, Denner J: Porcine endogenous retroviruses inhibit human immune cell function: risk for xenotransplantation? Virology, 2000; 268: 87-93
30. Akiyoshi DE, Denaro M, Zhu H et al: Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J Virol, 1998; 72: 4503-7
31. van der Laan LJ, Lockey C, Griffeth BC et al: Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature, 2000; 407: 90-94
32. Clémenceau B, Jégou D, Martignat L, Saï P: Microchimerism and transmission of porcine endogenous retrovirus from a pig cell line or specific pathogen-free pig islets to mouse tissues and human cells during xenografts in nude mice. Diabetologia, 2002; 45(6): 914-23
33. Deng YM, Tuch BE, Rawlinson WD: Transmission of porcine endogenous retroviruses in severe combined immunodeficient mice xenotransplanted with fetal porcine pancreatic cells. Transplantation, 2000; 70(7): 1010-16
34. Martina Y, Kurian S, Cherqui S et al: Pseudotyping of porcine endogenous retrovirus by xenotropic murine leukemia virus in a pig islet xenotransplantation model. Am J Transplant, 2005; 5(8): 1837-47
35. Irgang M, Karlas A, Laue C et al: Porcine endogenous retroviruses PERV-A and PERV-B infect neither mouse cells in vitro nor SCID mice in vivo. Intervirology, 2005; 48(2-3): 167-73
36. Goto M, Maeda A, Elfman L et al: No transmission of porcine endogenous retrovirus after transplantation of adult porcine islets into diabetic nude mice and immunosuppressed rats. Xenotransplantation, 2004; 11(4): 340-46
37. Denner J, Specke V, Karlas A et al: No transmission of porcine endogenous retroviruses (PERVs) in a long-term pig to rat xenotransplantation model and no infection of immunosuppressed rats. Ann Transplant, 2008; 13(1): 20-31
38. Heneine W, Tibell A, Switzer WM et al: No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet, 1998; 352(9129): 695-99
39. Garkavenko O, Croxson MC, Irgang M et al: Monitoring for presence of potentially xenotic viruses in recipients of pig islet xenotransplantation. Journal of Clinical Microbiology, 2004; 42(11): 5353-56
40. Zhang WJ, Laue C, Hyder A, Schrezenmeir J: Purity of alginate affects the viability and fibrotic overgrowth of encapsulated porcine islet xenografts. Transplant Proc, 2001; 33: 3517-19
41. Fiebig U, Stephan O, Kurth R, Denner J: Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation? Virology, 2003; 307: 406-13
42. Irgang M, Sauer I, Karlas A et al: Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells. J Clin Virol, 2003; 28: 141-54
43. Denner J, Specke V, Thiesen U et al: Genetic alterations of the long terminal repeat of an ecotropic porcine endogenous retrovirus (PERV) during passage in human cells. Virology, 2003; 314: 125-33
44. Nathan DM: Long-term complications of diabetes mellitus. N Engl J Med, 1993; 328: 1676-85
45. Hering BJ, Wijkstrom M, Graham ML et al: Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med, 2006; 12(3): 301-3
46. Tucker A, Belcher C, Moloo B et al: The production of transgenic pigs for potential use in clinical xenotransplantation: microbiological evaluation. Xenotransplantation, 2002; 9: 191-202
47. Denner J: Is porcine endogenous retrovirus (PERV) transmission still relevant? Transplant Proc, 2008; 40(2): 587-89
48. Martin U, Kiessig V, Blusch JH et al: Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet, 1998; 352: 692-94
49. Martin U, Steinhoff G, Kiessig V et al: Porcine endogenous retrovirus (PERV) was not transmitted from transplanted porcine endothelial cells to baboons in vivo. Transpl Int, 1998; 11: 247-51
50. Petersen P, Lembert N, Zschocke P et al: Hydroxymethylated polysulphone for islet macroencapsulation allows rapid diffusion of insulin but retains PERV. Transplant Proc, 2002; 34(1): 194-95
51. Pakhomov O, Martignat L, Honiger J et al: AN69 hollow fiber membrane will reduce but not abolish the risk of transmission of porcine endogenous retroviruses. Cell Transplant, 2005; 14(10): 749-56
52. Dieckhoff B, Karlas A, Petersen B et al: Knockdown of porcine endogenous retrovirus (PERV) expression by PERV-specific shRNA in transgenic pigs. Xenotransplantation, 2008; 15: 36-45
53. Denner J: Recombinant porcine endogenous retroviruses (PERV-A/C): A new risk for xenotransplantation? Arch Virol, 2008; 153: 1421-26
54. Paradis K, Langford G, Long Z et al: Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science, 1999; 285: 1236-41
55. Czauderna F, Fischer N, Boller K et al: Establishment and characterization of molecular clones of porcine endogenous retroviruses replicating on human cells. J Virol, 2000; 74: 4028-38
56. Le Tissier P, Stoye JP, Takeuchi Y et al: Two sets of human-tropic pig retrovirus. Nature, 1997; 389: 681-82
57. Switzer WM, Shanmugam V, Chapman L, Heneine W: Polymerase chain reaction assays for the diagnosis of infection with the porcine endogenous retrovirus and the detection of pig cells in human and nonhuman recipients of pig xenografts. Transplantation, 1999; 68: 183-88.